Taken together, our results indicate that the interrelation between the PI3K/AKT/mTOR and the PI3K/PKC/RhoA pathways may contribute to the drug resistance of MM cells against dexamethasone mediated by the BM mesenchymal stromal and OC niches. The gene discussed is PRRT2; the disease is Miyoshi myopathy.